Virtual Medicinal Product (VMP)
-
Trastuzumab 150mg powder for solution for infusion vials
Name Details
Current Name
Trastuzumab 150mg powder for solution for infusion vials
|
Start Date
15-01-2009
|
End Date
|
Previous Name
Trastuzumab 150mg powder for solution for injection vials
|
Start Date
11-06-2004
|
End Date
14-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FD01
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
10-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41772111000001108 |
09-05-2023 |
|
327399009 |
11-08-2005 |
08-05-2023 |
4812011000001108 |
26-08-2003 |
10-08-2005 |
VMP Ingredients
VMP ingredients table
Trastuzumab |
Based on Ingredient Substance |
|
150 mg |
|
Name
Trastuzumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Parent Products
-
VTM
Trastuzumab
-
VMP
(Current) Trastuzumab 150mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information